Production (Stage)
BriaCell Therapeutics Corp.
BCT.TO
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.01M | 5.79M | 862.10K | 935.70K | 6.24M |
| Total Receivables | 2.15M | 2.43M | 736.40K | 15.20K | 30.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 2.06M | 4.58M | 5.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.16M | 8.22M | 3.65M | 5.53M | 11.74M |
|
|
|||||
| Total Current Assets | 7.16M | 8.22M | 3.65M | 5.53M | 11.74M |
| Net Property, Plant & Equipment | 342.50K | 365.30K | 388.20K | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 192.20K | 196.00K | 199.80K | 203.60K | 207.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.21M | 1.21M | 1.21M | -- | -- |
| Total Assets | 9.36M | 10.41M | 5.87M | 6.20M | 12.23M |
|
|
|||||
| Total Accounts Payable | 5.00M | 4.23M | 7.17M | 6.42M | 3.71M |
| Total Accrued Expenses | 227.60K | 754.70K | 290.40K | 335.40K | 212.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.23M | 4.99M | 7.46M | 6.76M | 3.92M |
|
|
|||||
| Total Current Liabilities | 5.23M | 4.99M | 7.46M | 6.76M | 3.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 905.80K | 1.71M | 1.10M | 5.68M | 16.62M |
| Total Liabilities | 6.14M | 6.70M | 8.56M | 12.44M | 20.55M |
|
|
|||||
| Common Stock & APIC | 85.45M | 82.04M | 72.17M | 69.59M | 69.59M |
| Retained Earnings | -97.54M | -91.25M | -85.44M | -84.23M | -85.95M |
| Treasury Stock & Other | 15.69M | 13.25M | 10.89M | 8.67M | 8.28M |
| Total Common Equity | 3.60M | 4.04M | -2.38M | -5.97M | -8.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.60M | 4.04M | -2.38M | -5.97M | -8.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -376.00K | -329.60K | -302.50K | -267.90K | -244.40K |
| Total Equity | 3.23M | 3.71M | -2.68M | -6.23M | -8.32M |
|
|
|||||